secwatch / observer
8-K filed June 13, 2023, 7:59 PM ET CIK 0001651407
other material confidence high sentiment neutral materiality 0.50

Checkpoint Therapeutics shareholders approve 30M share increase and 3M plan expansion

Checkpoint Therapeutics, Inc.

item 5.02item 5.07item 5.03item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.96

Checkpoint Therapeutics, Inc.: Stockholders approved an amendment to the Amended and Restated Certificate of Incorporation to increase authorized common stock from 50,000,000 to 80,000,000 shares (effective 2023-06-12).

Change
charter amendment
Effective
2023-06-12
Exact text from the filing
As described under Item 5.07 of this Current Report, on June 12, 2023, the stockholders of the Company voted at the 2023 Annual Meeting to approve an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock authorized for issuance by 30,000,000 shares, bringing the total number of authorized shares of common stock to 80,000,000 shares (the “Amendment”). On June 12, 2023, following the 2023 Annual Meeting, the Company filed a certificate of amendment (the “Certificate”) giving effect to the Amendment with the Secretary of State of the State of Delaware.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Checkpoint Therapeutics, Inc. shareholders approved Approval of an amendment to the Amended and Restated Certificate of Incorporation to increase authorized shares of common stock by 30,000,000 shares from 50,000,000 to 80,000,000 shares. at the 2023-06-12 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-06-12
Exact text from the filing
Proposal 3 The votes with respect to the approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the Company’s authorized shares of common stock by 30,000,000 shares from 50,000,000 to 80,000,000 shares were as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 23,701,570 1,952,172 82,983 -
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Checkpoint Therapeutics, Inc. shareholders approved Approval of an amendment to the Amended and Restated 2015 Incentive Plan to increase shares available for issuance by 3,000,000 shares from 3,000,000 to 6,000,000 shares. at the 2023-06-12 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-06-12
Exact text from the filing
Proposal 4 The votes with respect to the approval of an amendment to the Company’s Amended and Restated 2015 Incentive Plan to increase the shares of common stock available for issuance thereunder by 3,000,000 shares from 3,000,000 to 6,000,000 shares were as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 19,415,164 1,092,366 70,681 5,158,514
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Checkpoint Therapeutics, Inc. shareholders approved Election of seven directors to hold office until the 2024 annual meeting. at the 2023-06-12 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-12
Exact text from the filing
Proposal 1 The votes with respect to the election of seven directors to hold office until the 2024 annual meeting were as follows: Director For % Voted For Withheld % Voted Withheld Broker Non- Votes Michael S. Weiss 20,158,708 97.96% 419,503 2.04% 5,158,514 Christian Béchon 20,105,163 97.70% 473,048 2.30% 5,158,514 Scott Boilen 20,073,637 97.55% 504,574 2.45% 5,158,514 Neil Herskowitz 20,038,631 97.38% 539,580 2.62% 5,158,514 James F. Oliviero 20,087,496 97.62% 490,715 2.38% 5,158,514 Lindsay A. Rosenwald, M.D. 20,086,381 97.61% 491,830 2.39% 5,158,514 Barry Salzman 20,032,418 97.35% 545,793 2.65% 5,158,514
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Checkpoint Therapeutics, Inc. shareholders approved Ratification of KPMG LLP as the independent registered accounting firm for the year ending December 31, 2023. at the 2023-06-12 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-12
Exact text from the filing
Proposal 2 The votes with respect to the ratification of KPMG LLP as the Company’s independent registered accounting firm for the year ending December 31, 2023 were as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 25,262,214 156,852 317,659 -
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001104659-23-070581
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.